CSJA:FRA
CSL ADR
€ 29.20
arrow_upward
+1.39%(+0.40) Siku 1
18 Nov, 22:00:00 GMT +1 · EUR
search
Alama zote
| Alama | Bei | Tofauti | Tofauti ya asilimia |
|---|
insights_autoInatayarisha maarifa maarufu ya CSJA...
Fungua
€ 27.60
Juu
€ 29.20
Chini
€ 27.60
Mtaji wa soko
94.98B
Wastani wa kiasi cha mauzo
0.00
Kiasi cha mauzo ya hisa
40.00
Juu kwa wiki 52
€ 43.40
Chini kwa wiki 52
€ 12.70
Idadi ya wafanyakazi
elfu 29
Fungua
€ 27.60
Juu
€ 29.20
Chini
€ 27.60
Mtaji wa soko
94.98B
Wastani wa kiasi cha mauzo
0.00
Kiasi cha mauzo ya hisa
40.00
Juu kwa wiki 52
€ 43.40
Chini kwa wiki 52
€ 12.70
Idadi ya wafanyakazi
elfu 29
Habari
Kutoka kwenye vyanzo vya wavuti na washirika wa habari
Kalkine
·
dakika 35 zilizopita
CSL Limited Buys Back 57,396 Shares on 18 November 2026 Under $1.15 Billion Program
Kalkine
·
saa 11 zilizopita
CSL (ASX:CSL) Shares Gain 11% Over a Year. What Should Investors Watch in the Restructuring?
Kalkine
·
siku 1 iliyopita
CSL Limited Buys Back 42,434 Shares on 17 November 2026 Under $1.15 Billion Program
Wasifu
CSL Limited is an Australian multinational specialty biotechnology company that researches, develops, manufactures, and markets products to treat and prevent serious human medical conditions. CSL's product areas include blood plasma derivatives, vaccines, antivenom, and cell culture reagents used in various medical and genetic research and manufacturing applications. The company was established in 1916 as Commonwealth Serum Laboratories and was wholly owned by the Australian federal government until its privatisation in 1994. Wikipedia
Kuhusu CSL ADR
Afisa Mkuu Mtendaji (CEO)Paul McKenzie
Wafanyakazielfu 29
Lilianzishwa1916
Makao makuuMelbourne, Victoria, Australia
SektaHealth Care
Sekta-
Tovuticsl.com